Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

mundipharma medical company, hamilton, bermuda, basel branch - hydromorphoni hydrochloridum - capsule - hydromorphoni hydrochloridum 2.6 mg corresp. hydromorphonum 2.31 mg, cellulosum microcristallinum, lactosum 78.7 mg, kapselhülle: gelatina, natrii laurilsulfas corresp. natrium 0.008 mg, e 127, e 172 (flavum), e 171, drucktinte: lacca, e 172 (nigrum), propylenglycolum, pro capsula. - un narcotico analgesico - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - ceritinibum - capsule - ceritinibum 150 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, carboxymethylamylum natricum a corresp. natrium 1.98 mg, magnesii stearas, silica colloidalis anhydrica, kapselhülle: gelatina, e 171, e 132, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio 28 per centum, pro capsula. - onkologikum - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

mundipharma medical company, hamilton, bermuda, basel branch - oxycodoni hydrochloridum - capsule - oxycodoni hydrochloridum 5 mg corresp. oxycodonum 4.48 mg, cellulosum microcristallinum, magnesii stearas, kapselhülle: e 110 0.02 mg, e 171, e 172 (rubrum), e 132, e 172 (flavum), natrii laurilsulfas corresp. natrium 0.006 mg, gelatina, drucktinte: lacca, e 172 (nigrum), propylenglycolum, pro capsula. - un narcotico analgesico - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

mundipharma medical company, hamilton, bermuda, basel branch - oxycodoni hydrochloridum - capsule - oxycodoni hydrochloridum 10 mg corresp. oxycodonum 8.97 mg, cellulosum microcristallinum, magnesii stearas, kapselhülle: e 171, e 172 (rubrum), e 132, e 172 (flavum), natrii laurilsulfas corresp. natrium 0.006 mg, gelatina, drucktinte: lacca, e 172 (nigrum), propylenglycolum, pro capsula. - un narcotico analgesico - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

mundipharma medical company, hamilton, bermuda, basel branch - oxycodoni hydrochloridum - capsule - oxycodoni hydrochloridum 20 mg corresp. oxycodonum 17.93 mg, cellulosum microcristallinum, magnesii stearas, kapselhülle: e 171, e 172 (rubrum), e 132, e 172 (flavum), natrii laurilsulfas corresp. natrium 0.006 mg, gelatina, drucktinte: lacca, e 172 (nigrum), propylenglycolum, pro capsula. - un narcotico analgesico - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

eisai pharma ag - lenvatinibum - capsule rigide - lenvatinibum 4 mg ut lenvatinibi mesilas, calcii carbonas, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum, hydroxypropylcellulosum substitutum humile, talcum, kapselhülle: hypromellosum, e 171, e 172 (flavum), e 172 (rubrum), drucktinte: lacca, e 172 (nigrum), kalii hydroxidum, propylenglycolum, pro capsula. - onkologikum - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

eisai pharma ag - lenvatinibum - capsule rigide - lenvatinibum 10 mg ut lenvatinibi mesilas, calcii carbonas, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum, hydroxypropylcellulosum substitutum humile, talcum, kapselhülle: hypromellosum, e 171, e 172 (flavum), e 172 (rubrum), drucktinte: lacca, e 172 (nigrum), kalii hydroxidum, propylenglycolum, pro capsula. - onkologikum - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

eisai pharma ag - lenvatinibum - capsule - lenvatinibum 4 mg ut lenvatinibi mesilas, calcii carbonas, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum, hydroxypropylcellulosum substitutum humile, talcum, kapselhülle: hypromellosum, e 171, e 172 (flavum), e 172 (rubrum), drucktinte: lacca, e 172 (nigrum), kalii hydroxidum, propylenglycolum, pro capsula. - behandlung von fortgeschrittenem nierenzellkarzinom (rcc) - synthetika

Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

eisai pharma ag - lenvatinibum - capsule - lenvatinibum 10 mg ut lenvatinibi mesilas, calcii carbonas, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum, hydroxypropylcellulosum substitutum humile, talcum, kapselhülle: hypromellosum, e 171, e 172 (flavum), e 172 (rubrum), drucktinte: lacca, e 172 (nigrum), kalii hydroxidum, propylenglycolum, pro capsula. - behandlung von fortgeschrittenem nierenzellkarzinom (rcc) - synthetika

Italia - Italia - AIFA (Agenzia Italiana del Farmaco)

fisiopharma s.r.l. - lidocaina - lidocaina